Can infections trigger neural autoantibodies through molecular mimicry and bystander inflammation?

Infections can precipitate neuroimmune autoimmunity, but the strength of evidence depends importantly on the pathogen, neural target, and proposed mechanism.

Clinical and mechanistic evidence

• The clearest causal model is Campylobacter jejuni–associated Guillain–Barré syndrome (GBS). Sialylated bacterial lipooligosaccharides structurally resemble peripheral-nerve gangliosides—including GM1, GD1a, GT1a, GQ1b, and GD3—creating molecular mimicry.
• Patient sera and monoclonal antibodies recognize both C. jejuni lipooligosaccharides and neural gangliosides. In some patients, autologous bacterial antigen inhibited 90–100% of anti-ganglioside serum reactivity, directly supporting a cross-reactive immune response.
• These antibodies have functional relevance: experimental anti-ganglioside antibodies bind ganglioside-rich neural structures, including nodes of Ranvier, and impair neuromuscular transmission. Thus, microbial immune responses can generate pathogenic antibodies directed at peripheral nerves.

Broader neuroimmune activation

• Infection-associated immune activation is linked to neuroimmune cross-reactivity beyond GBS, but findings are heterogeneous. In severe Neuro-COVID, paired CSF/plasma studies found polyreactive immunoglobulins and antineuronal-associated immune signatures, without increased established MOG or NF155 reactivity.
• In prospective COVID-19 cohorts, anti–SARS-CoV-2 antibodies in CSF often lacked intrathecal synthesis; neuronal-surface autoantibodies were rare and did not correlate with symptoms, suggesting that blood–CSF barrier leakage can explain some findings. Other longitudinal data found persistent new-onset autoantibodies, including some reactivities with Spike-epitope similarity and neuropsychiatric associations.

Inflammatory mechanisms

• Bystander inflammation is biologically credible: cytokines, pattern-recognition signaling, activated antigen-presenting cells, and tissue injury can activate autoreactive lymphocytes and expose neural antigens. Direct human proof that this process independently causes incident pathogenic neural-autoantibody production remains less definitive than mimicry.

Bottom line

• Molecular mimicry is an established cause of infection-triggered pathogenic neural autoantibodies in selected syndromes, especially C. jejuni–GBS. Inflammatory bystander activation plausibly contributes, but its direct role in humans is less firmly demonstrated and should not be assumed across all infections or neurologic symptoms.